Coastal Infusion Administers Aduhelm™
| J-Code | J0172 |
|---|---|
| Manufacturer | Biogen |
| First Approved | 06/07/2021 |
Aduhelm will be discontinued by the manufacturer on November 1, 2024. If your doctor has prescribed an alternative, like Leqembi or Kisunla, Coastal Infusion can administer your infusions.
Aduhelm (aducanumab-avwa) is used for the treatment of Alzheimer’s disease, a progressive and degenerative brain disorder that affects memory, thinking, and behavior. Aduhelm may help clear amyloid plaques, abnormal clumps of protein in the brain that are a characteristic of Alzheimer’s disease which build up in the brain over time and may lead to the loss of brain function. By removing these plaques, Aduhelm may slow the progression of the disease and improve cognitive function.
Aduhelm will be discontinued by the manufacturer on November 1, 2024.
What It Treats
Aduhelm is used to treat Alzheimer’s Disease.
Prescribed By
Aduhelm is most often prescribed by Neurologists.
How it’s Administered
Aduhelm is administered by intravenous infusion. Aduhelm infusions take about an hour.
Frequency
Aduhelm is generally administered every four weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies